CCM
MRK icon

CrestPoint Capital Management’s Merck MRK Stock Holding History

CrestPoint Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$838K Sell
15,615
-16,978
-52% -$941K 0.47% 79
2017
Q3 		$1.99M Buy
32,593
+1,572
+5% +$95.3K 0.89% 22
2017
Q2 		$1.9M Buy
31,021
+210
+0.7% +$12.8K 0.89% 21
2017
Q1 		$1.87M Buy
30,811
+1,048
+4% +$63.6K 0.89% 25
2016
Q4 		$1.67M Sell
29,763
-315
-1% -$18.4K 0.84% 28
2016
Q3 		$1.79M Sell
30,078
-314
-1% -$18.4K 0.92% 23
2016
Q2 		$1.67M Sell
30,392
-524
-2% -$27.9K 0.89% 30
2016
Q1 		$1.56M Buy
30,916
+15,406
+99% +$755K 0.85% 33
2015
Q4 		$782K Sell
15,510
-629
-4% -$31.7K 0.44% 81
2015
Q3 		$761K Sell
16,139
-1,048
-6% -$55.7K 0.44% 88
2015
Q2 		$934K Buy
17,187
+629
+4% +$35.3K 0.49% 67
2015
Q1 		$908K Buy
16,558
+838
+5% +$47.5K 0.47% 73
2014
Q4 		$852K Buy
15,720
+3,144
+25% +$175K 0.46% 83
2014
Q3 		$711K Sell
12,576
-31
-0.2% -$1.74K 0.43% 90
2014
Q2 		$696K Sell
12,607
-420
-3% -$22.9K 0.41% 99
2014
Q1 		$706K Sell
13,027
-2,096
-14% -$109K 0.44% 92
2013
Q4 		$722K Buy
+15,123
New +$691K 0.48% 78

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CrestPoint Capital Management's MRK Position: Q4 2017 in Review

CrestPoint Capital Management reduced its Merck (MRK) stake by 52% in Q4 2017, selling an estimated $941K and leaving 15,615 shares worth $838K. The position accounts for 0.47% of the portfolio, ranked #79.

CrestPoint Capital Management first reported a position in MRK in Q4 2013 and has held it in 17 quarters since. The position peaked at $1.99M in Q3 2017. 2,009 funds tracked by Wall St. Rank hold MRK as of Q4 2017.

  • CrestPoint Capital Management held 15,615 shares of Merck worth $838K as of Q4 2017.
  • CrestPoint Capital Management sold 16,978 Merck shares in Q4 2017, an estimated $941K.
  • Merck made up 0.47% of CrestPoint Capital Management's portfolio in Q4 2017, its #79 holding.
  • CrestPoint Capital Management first reported a position in Merck in Q4 2013 and has held it in 17 quarters since.
  • CrestPoint Capital Management's Merck position peaked at $1.99M in Q3 2017.
  • 2,009 funds tracked by Wall St. Rank held Merck as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.